HP126-17-Alcohol-Editorial

Document Sample
HP126-17-Alcohol-Editorial Powered By Docstoc
					944
                                         Barbero-Becerra VJ, et al.                      , 2012; 11 (6): EDITORIAL
                                                                                                         944-948

                                                                                         November-December, Vol. 11 No.6, 2012: 944-948




              Alcohol effects on liver diseases: good or bad buddy?
                                    Varenka J. Barbero-Becerra, Jorge A. López-Velázquez,
                                 Vicente Sánchez-Valle, Misael Uribe, Nahum Méndez-Sánchez

                                      Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.



   Alcohol consumption in developing countries is                            tological levels,6 as well as high levels of hepatic ac-
increasing significantly and progressively it has be-                        tivity markers; alanine aminotransferase (ALT), as-
come a major risk factor for chronic liver disease                           partate aminotransferase (AST), and biochemical
worldwide. As a matter of fact, it has been conside-                         marker of alcohol intake, gamma-glutamyltransfera-
red one of the major etiologies of liver diseases.1 Al-                      se (GGT), which were related to a more severe grade
coholic persons are thought to be prone to various                           of injury in chronic hepatitis C patients.7 However,
infections, such as hepatitis C, in which the severity                       an increase of hepatitis C virus (HCV) RNA titers2
of damage is related with ethanol consumption.2 Ac-                          has been observed as well as an increase in viral re-
cording to epidemiological data, alcohol related liver                       plication rate according to the drinking patterns.8
deaths is one of the leading causes of mortality in                             Furthermore, alcohol intake has been associated
western and latinoamerican countries.3                                       with a poor response to interferon therapy in pa-
   Recently, research on alcohol effects has been                            tients with viral hepatitis B9 and viral hepatitis
growing increasingly from several points of view,                            C.2,6,10 The way in which this biological phenomenon
mainly in terms of health benefits and risks. For a                          develops is not well known. Evidence supports,
long time, alcohol intake was conceived as represen-                         however, the hypothesis that alcohol may pontentia-
ting some kind of “danger” for human health. In-                             te hepatitis C viral infection by immune-mediated
deed, the main clinical recommendation to patients                           factors probably due to a change in cell-mediated im-
who suffer liver disorders have been lies on complete                        munity and modulated interferon therapy,2 impai-
abstinence from alcohol.4 However, it has been sug-                          ring the immune system’s viral response.10
gested that modest alcohol consumption, that is to                              It is well known that alcohol metabolism is consi-
say up to two drinks per day, was associated with                            dered to be the principal cause of liver damage. The
less severity of fibrosis and hepatocellular injury                          study of alcohol metabolism includes several com-
in steatohepatitis.5 Whether patients with liver di-                         plex mechanisms and endotoxins involved in liver
sease should abstain from alcohol or rather be allo-                         injury.1 There are 2 main pathways of alcohol meta-
wed modest alcohol consumption remains still                                 bolism, alcohol dehydrogenase and cytochrome
unknown.                                                                     P-450 2E1 (CYP2E1). Alcohol dehydrogenase is the
   There are certain clinical alcohol effects which                          main participant in alcohol metabolism, its primary
have been examined in several chronic conditions                             effect focuses on alcohol oxidization to acetaldehyde,
such as obesity, chronic viral hepatitis C, non alco-                        and it is considered the key toxin in alcohol-media-
holic fatty liver disease (NAFLD), non alcoholic                             ted liver injury by promoting cellular damage, inflam-
steatohepatitis (NASH), and alcoholic liver disease                          mation, extracellular matrix remodeling and
(Tables 1 and 2). Clinical studies in viral hepatitis C                      fibrosis.11 Acetaldehyde binds through covalent
have shown a progressive liver damage effect at his-                         bonds to proteins and DNA forming adducts such as
                                                                             malondialdehyde, which directly affects cell functions
                                                                             and contributes to liver injury by lipid peroxidation
                                                                             of the cellular membrane. 12 On the other hand,
Correspondence and reprint request: Dr. Nahum Mendez-Sanchez, MD, MSc,
PhD, FACG, AGAF.
                                                                             alcohol oxidation also occurs via cytochrome P450
Liver Research Unit, Medica Sur Clinic & Foundation.                         to cause tissue injury by generating reactive oxygen
Puente de Piedra 150, Col. Toriello Guerra, Tlalpan 14050, Mexico City,      species (ROS) such as, hydrogen peroxide (H2O 2)
Mexico.                                                                      and superoxide ions.13 This event coupled with a de-
Phone: (+525) 55424-7200. Ext. 4211. Fax: (+525)55 666-4031.
                                                                             crease in cellular antioxidant levels in blood and li-
                              Manuscript received: September 21, 2012.       ver, like glutathione (GSH),14 lead to enhaced tissue
                              Manuscript accepted: September 21, 2012.       injury.
                                                                                                                                                945
                                   Alcohol effects on liver diseases .                   , 2012; 11 (6): 944-948



   The convertion of alcohol to acetate enhances his-                          not a correlation of HCV RNA levels between drin-
tone acetylation at specific cytokine gene promoters,                          king patients and not drinking patients.10,7 In fact,
such as interleukin-6 (IL-6), IL-8 and tumor necro-                            it has been postulated that the damaging effect of
sis factor-alpha (TNF-α); this regulates the protein                           ethanol and HCV is simply additive.21 This evidence
synthesis and promotes inflammation in acute alco-                             points out the idea that HCV and not alcohol prima-
holic hepatitis.15 Furthermore, the role of alcohol                            rily mediated hepatocyte damage, suggesting that al-
has been related to metabolism in mitogenesis acti-                            cohol intake is an independent risk factor in the
vation, oncogenesis,16 and as an immuno modulator                              clinical and histological progression of HCV infec-
and apoptosis inhibitor.17                                                     tion.10
   These inflammatory events have been described at                               Dose consumption seems to be a key point in de-
several hepatic lineage cells.18,15 In hepatocytes,                            termining if alcohol promotes a benefit or risk in li-
ROS is generated from both mechanisms, alcohol                                 ver disease patients (Tables 1 and 2). A modest
deshidrogenase and CYP2E1 pathways, while nitric                               alcohol consumption seems to protect the liver from
oxide (NO) and reduced form of nicotinamide adeni-                             NASH and NAFLD5 (Table 2), meanwhile higher al-
ne dinucleotide phosphate (NADPH) oxidase are                                  cohol doses lead to damage effects 22 (Table 1).
produced by Kupffer cells.18 These mechanisms                                  However, it has been suggested that drinking fre-
affect several macromolecules, such as proteins, li-                           quency might be more important than the quantity
pids and DNA. The biological importance in cellular                            consumed on each occasion,23 as well as the quality
systems lies in their participation in certain molecu-                         of alcohol,24 where Gronbaek et al. suggests that
lar pathways that converge in the development of al-                           drinking wine could promote a lower risk of develo-
coholic liver disease.1                                                        ping alcoholic cirrhosis as compared to drinking
   Novel and promising findings underpin that alco-                            beer or spirits in a metabolic syndrome swine mo-
hol could benefit some particular pathological condi-                          del.25 Unfortunately, there is insufficient evidence to
tions.19,20 Several studies demonstrated that there is                         establish whether quality of alcohol had a major im-


Table 1. Comparison of studies investigating alcohol harmful effects in liver diseases.

    Study                     Population                           Dose                        Study design              Harmful effect

    Oshita,                   53 patients with chronic             IFNα/daily therapy          Clinical study.           Alcohol potentiated
    et al. 1994.              HCV hepatitis.                       ≥ 60g/day ethanol                                     HCV replication in
                              16/37 habitual/                      for 5 years.                                          patients with hepatitis C.
                              non-habitual drinkers.
    Cromie,                   45 patients with                     Two groups:                 Follow-up study           Alcohol aggravates
    et al. 1996.              chronic hepatitis C.                 alcohol intake of           alcohol intake            hepatic injury
                                                                   > 10g/day and               moderation.               in chronic hepatitis
                                                                   ≤ 10g/day.                                            C patients,
                                                                                                                         and viral load.

    Pessione,                 233 chronic hepatitis C              < 140g/per week             Cross-sectional           Direct role of alcohol
    et al. 1998.              carriers with                        in 80% patients.            study.                    on HCV replication and/or
                              alcohol consume.                                                                           HCV clearance in
                                                                                                                         association with a poor
                                                                                                                         response to interferon
                                                                                                                         therapy.
    Hézode,                   260 patients with                    31-50 g/day in men and      Prospective               Moderate alcohol
    et al. 2003.              chronic hepatitis C.                 21-50 g/day in women.       study.                    consumption may
                                                                                                                         aggravate histological
                                                                                                                         lesions in patients with
                                                                                                                         chronic hepatitis C.
    Ruhl,                     13,580 adults from                   > 2 drinks per day.         Population                Overweight and
    et al. 2005.              the NHNES 1988-1994                                              based study.              obesity increased the
                              (overweight and                                                                            risk of alcohol-related
                              obese persons).                                                                            abnormal
                                                                                                                         aminotransferase activity.

HCV: hepatitis C virus. IFNα: interferon alpha. NHNES: National Health and Nutrition Examination Survey. Ab: antibody.
946
                                            Barbero-Becerra VJ, et al.                    , 2012; 11 (6): 944-948


Table 2. Comparison of studies investigating alcohol beneficial effects in liver diseases.

    Study                      Population                          Dose                       Study design            Beneficial effect

    Wiley,                     176 HCV Ab-positive                 40g alcohol/day            Retrospective           Alcohol is an independent
    et al. 1998                patients with moderate              women and > 60g            study.                  risk factor in
                               alcohol intake.                     alcohol/day men                                    HCV progression.
                                                                   exposure average 21
                                                                   years. Two groups:
                                                                   HCV only and
                                                                   HCV/alcohol.
    Westin,                    78 untreated patients               < 40 g/day ethanol.        Retrospective.          Drinking frequency is
    et al. 2002                with HCV infection                  Median = 4.8 g/day.                                independently associated
                               and moderate                                                                           with fibrosis progression.
                               alcohol consumption.
    Dunn,                      Suspected NAFLD in                  ≤ 7 drinks per week.       Cross-sectional         Moderate wine drinking
    et al. 2008                11,754 adults.                                                 study.                  was associated with lower
                                                                                                                      prevalence of NAFLD.
    Dunn,                      NAFLD patients                      ≤ 2 drinks/day.            Cross-sectional         Modest alcohol consumption
    et al. 2012                251/331 non-drinkers/                                          analysis.               associates with lesser
                               modest drinkers                                                                        severity and fibrosis stage.
                               with modest
                               alcohol consumption.

HCV: hepatitis C virus. Ab: antibody. NAFLD: Non alcoholic fatty liver disease.




                                                                    Obesity
                                      NAFLD/NASH
                                                                                              Insulin sensitivity


                                                     ¿?

                                           ¿?
                                                                                                        Cardiovascular
    Chronic viral hepatitis
                                                          Alcohol consumption                              effects          Figure 1. Factors as-
                                                                                                                            sociated to alcohol
                                                                                                                            consumption and the
                                                                                                                            clinical implications in
                                                                                                                            several hepatic condi-
                                                                                                                            tions. Red arrows re-
                                                                                                                            present a harmful
                                                                                                                            effect. Green arrows
             Gender/Dietary factors                                                                                         represent a beneficial
                                                                                                   Kind of alcohol/         effect of alcohol con-
                                                                                                      Frequency             sumption in liver di-
                                                               Genetics
                                                                                                                            seases.


pact on disease burden. Moreover, consumption of                                  mention that overweight and obesity have been well
alcohol without food was associated with an increa-                               described to increase the risk of alcohol-related ab-
sed prevalence of alcohol related liver disease.24                                normal aminotransferase activity.26 In animal mo-
   Despite the strong evidence which supports the                                 dels, it has been shown that this condition worsens
potential benefits of alcohol consumption, we should                              glucose metabolism by altering activation of the in-
                                                                                                                                 947
                              Alcohol effects on liver diseases .            , 2012; 11 (6): 944-948



sulin signaling pathway in the liver and skeletal                       jury and economic cost attributable to alcohol use and al-
                                                                        cohol-use disorders. Lancet 2009; 373: 2223-33.
muscle.27,28                                                        4. Tome S, Lucey M. Review article: current management of
   It is important to mention that alcohol con-                         alcoholic liver disease. Aliment. Pharmacol Ther 2004; 19:
sumption not only impacts in liver pathologies, it                      707-14.
has also suggested a direct relation between modera-                5. Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M,
                                                                        McCullough AJ, Schwimmer JB. Modest alcohol consumption
te alcohol consumption and insulin sensitivity29 sug-                   is associated with decreased prevalence of steatohepati-
gesting that alcohol could have a role in reduced                       tis in patients with non-alcoholic fatty liver disease (NA-
risk of diabetes.30,31,32 In addition, it has been rela-                FLD). J Hepatol 2012; 57: 384-39.
ted to cardiovascular events associated with liver                  6. Pessione F, Degos FO, Marcellin P, Duchatelle V, Njapoum C,
                                                                        Martinot PM, Degott C, et al. Effect of Alcohol Consumption
enzymes and gamma glutamyl transpeptidase                               on Serum Hepatitis C Virus RNA and Histological Lesions in
(GGT), which predisposed NAFLD patients to deve-                        Chronic Hepatitis C. Hepatology 1998;27:1717-22.
lop metabolic disorders concomitant with a signifi-                 7. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic he-
cant risk for coronary artery disease.30,33,34                          patitis C: effect of alcohol on hepatitic activity and viral
                                                                        titre. J Hepatol 1996; 25: 821-6.
However, moderate alcohol consumption was asso-                     8. Balasubramanian S, Kowdley K. Effect of Alcohol on Viral
ciated with a decreased incidence of heart disease in                   Hepatitis and Other Forms of Liver Dysfunction. Clin Li-
persons with diabetes.32                                                ver Dis 2005; 9: 83-101.
   Low levels of alcohol intake have been inversely                 9. Nomura H, Hayashi J, Kajiyama W, Kashiwagi S. Alcohol
                                                                        consumption and seroconversion from hepatitis B e anti-
associated with total mortality in both men and wo-                     gen in the Okinawa Japanese. Fukuoka Igaku Zasshi 1996;
men,35 it seems that benefit depended in part on age,                   87: 237-41.
since mortality (relative risk) of several cancer di-               10. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ.
seases was higher in drinking adults, but in middle-                    Impact of Alcohol on the Histological and Clinical Progression
                                                                        of Hepatitis C Infection. Hepatology 1998; 28: 805-09.
aged and elderly population, moderate alcohol                       11. Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic
consumption slightly reduced overall mortality.36                       fibrosis: role of acetaldehyde. Mol Aspects Med 2008; 29:
   In clinical conditions where several variables im-                   17-21.
pact disease progression (Figure 1). It is difficult to             12. Niemela O. Distribution of ethanol-induced protein
                                                                        adducts in vivo: relationship to tissue injury. Free Radic
determine which factor has the main role in enhan-                      Biol Med 2001; 31: 1533-8.
cing disease progression; gender,37 drinking patterns,              13. Parola M, Robino G. Oxidative stress-related molecules
kind of alcohol, quantity, obesity, dietary factors,38                  and liver fibrosis. J Hepatol 2001; 35: 297-306.
clinical condition, non-sex-linked genetic factors and              14. Mato JM, Camara J, Fernandez de Paz J, Caballería L, Coll
                                                                        S, Caballero A, García-Buey L, et al. S-adenosylmethionine
smoking,37,39,40 It seems that alcohol intake per se                    in alcoholic liver cirrhosis: a randomized, placebo-contro-
does not determine liver damage and should be con-                      lled, double-blind, multicenter clinical trial. J Hepatol
sidered a multifactorial disease. Until further data                    1999: 30: 1081-9.
from rigorously conducted prospective studies beco-                 15. Kendrick SF, O’Boyle G, Mann J, Zeybel M, Palmer J, Jones
                                                                        DE, Day CP. Acetate, the key modulator of inflammatory
me available, multiple factors must be taken into                       responses in acute alcoholic hepatitis. Hepatology 2010;
consideration in order to evaluate whether a patient                    51: 1988-97.
is able to consume alcohol or not.                                  16. Alisi A, Ghidinelli M, Zerbini A, Missale G, Balsano C. Hepati-
   Further studies of cellular and molecular mecha-                     tis C virus and alcohol: same mitotic targets but different
                                                                        signaling pathways. J Hepatol 2011; 54: 956-63.
nisms should be contemplated in order to provide a                  17. Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mecha-
better understanding of the different mechanisms in-                    nisms involved in the interaction effects of alcohol and he-
volved and which will contribute to define the im-                      patitis C virus in liver cirrhosis. Mol Med 2010; 16:
portant steps along the therapeutic pipeline by                         287-97.
                                                                    18. Dey A, Cederbaum AI. Alcohol and oxidative liver injury.
identifying potential novel and specific therapeutic                    Hepatology 2006; 43: S63-S74.
targets.                                                            19. Suzuki A, Angulo P, St. Sauver J, Muto A, Okada T, Lindor
                                                                        K. Light to moderate alcohol consumption is associated
                        REFERENCES                                      with lower frequency of hypertransaminasemia. Am J Gas-
                                                                        troenterol 2007; 102: 1912-9.
1. Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of      20. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and
   alcohol-induced liver disease: classical concepts and recent         decreased prevalence of suspected nonalcoholic fatty li-
   advances. J Gastroenterol Hepatol 2011; 26: 1089-105.                ver disease. Hepatology 2008; 47: 1947–54.
2. Oshita M, Hayashi N, Kasahaela N, Hagiwaeu H, Mita E,            21. Anand BS, Thornby J. Alcohol has no effect on hepatitis
   Naito M, Katayama K, et al. Increased Serum Hepatitis C              C virus replication: a meta-analysis. Gut 2005; 54:
   Virus RNA Levels Among Alcoholic Patients with Chronic               1468-72.
   Hepatitis C. Hepatology 1994; 20: 1115-20.                       22. Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathie-
3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Tee-               sen UL, Bodemar G, Kechagias S. Alcohol consumption is
   rawattananon Y, Patra J. Global burden of disease and in-            associated with progression of hepatic fibrosis in non-al-
948
                                      Barbero-Becerra VJ, et al.                , 2012; 11 (6): 944-948


    coholic fatty liver disease. Scand J Gastroenterol 2009;              lower fasting glucagon concentration in healthy wo-
    44: 366-74.                                                           men. Diabetologia 2012.
23. Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh        31.   Wannamethee SG, Camargo CA, Manson JE, Willet WC,
    M, Dhillon AP, et al. Moderate alcohol intake increases               Rimm EB. Al cohol drinking patterns and risk of type 2 dia-
    fibrosis progression in untreated patients with hepatitis             betes mellitus among younger women. Arch Intern Med
    C virus infection. J Viral Hepatitis 2002; 9: 235-41.                 2003; 163: 1329-36.
24. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti        32.   Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol
    F, Sodde M, Saveria L, et al. Drinking habits as cofac-               consumption on diabetes mellitus: a systematic review.
    tors of risk for alcohol induced liver damage. Gut 1997;              Ann Intern Med 2004; 140: 211-9.
    41: 845-50.                                                     33.   Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic
25. Gronbaek M, Jensen MK, Johansen D, Sorensen T, Bec-                   fatty liver disease, and incident cardiovascular disease: a
    ker U. Intake of Beer, Wine and Spirits and Risk of Hea-              narrative review and clinical perspective of prospective
    vy Drinking and Alcoholic Cirrhosis. Biol Res 2004; 37:               data. Hepatology 2010; 52: 1156-61.
    195-200.                                                        34.   Liangpunsakul S, Chalasani N. What Should We Recommend
26. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B,
                                                                          to Our Patients with NAFLD Regarding Alcohol Use? Am J
    Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity
                                                                          Gastroenterol 2012; 107: 976-8.
    in nondiabetic patients with nonalcoholic steatohepatitis.
                                                                    35.   Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Ia-
    Hepatology 2003; 37: 544-50.
                                                                          coviello L, de Gaetano G. Alcohol dosing and total mortality
27. Ruhl CE, Everhart JE. Joint Effects of Body Weight and Al-
                                                                          in men and women: an updated meta-analysis of 34 pros-
    cohol on Elevated Serum Alanine Aminotransferase in the
    United States Population. Clinical Gastroenterology and               pective studies. Arch Intern Med 2006; 166: 2437-45.
    Hepatology 2005; 3: 1260-8.                                     36.   Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath
28. Elmadhun NY, Lassaletta AD, Chu LM. Vodka and wine con-               CW Jr, Doll R. Alcohol consumption and mortality among
    sumption in a swine model of metabolic syndrome alters in-            middle-aged and elderly U.S. adults. N Engl J Med 1997;
    sulin signaling pathways in the liver and skeletal muscle.            337: 1705-14.
    Surgery 2012; 152: 414-22.                                      37.   O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver di-
29. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Ta-               sease. Hepatology 2010; 51: 307-28.
    ylor PR. Effects of moderate alcohol intake on fasting in-      38.   Tsukamoto H, Machida K, Dynnyk A, Mkrtchyan H. “Se-
    sulin and glucose concentration and insulin sensitivity in            cond hit” models of alcoholic liver disease. Semin Liver Dis
    postmenopausal women: a randomized controlled trial.                  2009; 29: 178-87.
    JAMA 2002; 287: 2559-62.                                        39.   De Alwis WNM, Day CP. Genetics of alcoholic liver disease and no-
30. Bonnet F, Disse E, Laville M, Mari A, Hojlund K, An-                  nalcoholic fatty liver disease. Semin Liver Dis 2007; 27: 44-54.
    derwald CH, Piatti P, et al. Moderate alcohol con-              40.   Gao B, Bataller R. Alcoholic Liver Disease: Pathogenesis
    sumption      is  associated    with    improved      insulin         and New Therapeutic Targets. Gastroenterology 2011;
    sensitivity, reduced basal insulin secretion rate and                 141: 1572-85.

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:3
posted:2/23/2013
language:Latin
pages:5